Based on the recent market data and analysis, here's a concise assessment of UNH stock:
Technical Analysis
The stock is currently trading at $509.76, showing a slight decline of -0.16% in regular market hours . The stock has formed a consolidation pattern near the Fibonacci support level of $507.52, with resistance at $541.60.
Fundamental Strength
UnitedHealth remains fundamentally strong with analysts maintaining positive ratings. Bernstein recently reaffirmed their Outperform rating with a $697 price target, suggesting a 37% upside potential. The company's 2025 outlook is considered achievable, with improving Medicare Advantage trends.
Recent Performance & Valuation
The stock is currently trading at a forward P/E of 17.57x, below its 5-year average of 23.29x, indicating potential value at current levels. The RSI of 41.72 suggests the stock is neither overbought nor oversold.
Analyst Consensus
Multiple analysts maintain bullish ratings on UNH:
- Cantor Fitzgerald: Buy rating, $700 price target
- Keybanc: Buy rating, $650 price target
- Barclays: Buy rating, $642 price target
Recommendation
SELL. Despite strong fundamentals and positive analyst outlook, technical indicators suggest potential near-term weakness. The stock is testing support levels, and with the current market uncertainty and healthcare sector headwinds, it would be prudent to wait for a more attractive entry point below $500.